In normo-and hypoglycemic ferret lungs, the pulmonary vascular response to severe hypoxia (PiO2 < 10 mmHg) is characterized by an initial intense vasoconstriction followed by marked vasodilation, whereas in hyperglycemic lungs, vasodilation is minimal, causing vasoconstriction to be sustained. In contrast, the response to moderate hypoxia is characterized by a slowly developing sustained vasoconstriction which is unaffected by glucose concentration. To determine the role of ATP-dependent K+ (KATP) channels in these responses, we examined the effects of cromakalim, which opens KAT channels, and glibenclamide, which closes them. During steady-state vasoconstriction induced in isolated ferret lungs by moderate hypoxia, cromakalim caused dose-dependent vasodilation (EC5. = 7 X 10-M) which was reversed by glibenclamide (IC5o = 8 X 10-' M), indicating that KATP channels were present and capable of modulating vascular tone. During severe hypoxia in hypoglycemic lungs (Qglucosel < 1 mM), glibenclamide markedly inhibited the secondary vasodilation. Raising perfusate glucose concentration to 14±0.4 mM had the same effect. As a result, initial *asoconstrictor responses were well sustained. However, neither glibenclamide nor hyperglycemia affected vasoconstrictor responses to moderate hypoxia or KCI, indicating that effects during severe hypoxia were not due to nonspecific potentiation of vasoconstriction. These findings suggest that in the ferret lung (a) severe hypoxia decreased ATP concentration and thereby opened KATp channels, resulting in increased K+ efflux, hyperpolarization, vasodilation, and reversal of the initial vasoconstrictor response; and (b) hyperglycemia prevented this sequence of events. (J. Clin. Invest. 1991. 88:500-504.)
Introduction
In isolated lungs of several species, the pulmonary vascular response to inspired oxygen tensions < 10 mmHg is characterized by an initial intense vasoconstriction, followed by marked vasodilation (I1-3). In ferret lungs this vasodilation is inhibited by high glucose concentrations (15 mM) (3), suggesting that severe hypoxia limited some component ofthe vasoconstrictor response, perhaps by decreasing production of ATP. It is unlikely, however, that this ATP-dependent component was the contractile apparatus of vascular smooth muscle, because neither severe hypoxia nor glucose concentration affected pulmonary vasoconstrictor responses to KCl (3, 4) .
Recently, ATP-dependent K+ (KATp)' channels were described in myocardial cells (5) , vascular smooth muscle (6) (7) (8) (9) (10) , pancreatic beta-cells (1 1, 12) , and neurons (13) . These channels are thought to mediate cellular responses to changes in glucose and/or oxygen supply (10, 13, 14) . For example, when ATP concentration was decreased, KATP channels opened, causing increased K+ efflux and hyperpolarization (9, 14) . In vascular smooth muscle, this sequence ofevents caused vasodilation (6) (7) (8) (9) (10) . It is now appreciated that KATP channels can be opened (activated) by compounds such as diazoxide or cromakalim, and closed (inactivated) by sulfonylureas such as tolbutamide and glibenclamide (6, 14, 15) .
In this study, we hypothesized that the inability of pulmonary vessels to sustain vasoconstriction during severe hypoxia was caused by the opening ofKAT channels, and that hyperglycemia reversed this inability by increasing ATP production sufficiently to keep these channels closed. To test these hypotheses, we determined the effects of cromakalim and glibenclamide on hypoxic vasomotor responses of isolated ferret lungs exposed to high and low perfusate glucose concentrations.
Methods
Preparation. Adult male ferrets (1,100-1,900 g) were anesthetized with intraperitoneal sodium pentobarbital mg/kg) and ventilated with 30% 02 at a tidal volume of 12.5 ml/kg, a frequency of 10-12/min, and an end-expiratory pressure of 3-4 mmHg with a volume cycled ventilator (model 665; Harvard Apparatus, South Natick, MA). The abdomen was opened with a midline incision and heparin (1,000 U) was injected into the inferior vena cava. The animals were exsanguinated through a catheter placed in the abdominal aorta. After exsanguination, 5.0-5.4% CO2 was added to the inspired gas. The chest was opened at the midline and a metal cannula was placed in the main pulmonary artery. The left atrium was drained into a reservoir through a large plastic cannula inserted through the left ventricle. Using a peristaltic pump (Minipuls 2; Gilson Co., Inc. Middleton, WI), the isolated lungs were perfused at 100 ml -min-' -kg-1 through a bubble filter with -50 ml ofautologous blood mixed with -50 ml of 3% Dextran-70 in lactated Ringer's solution (perfusate hematocrit 20-25%). Left (25) (26) (27) (28) (29) (30) min), cromakalim was added to the perfusate in amounts calculated to achieve final concentrations of 10-8, 3 X 10-8, 10-7, 3 X 10-7, 10-6, and 3 X 10-6 M. Adequate time was allowed after each dose ofcromakalim for Ppa500 to achieve a new steady-state.
Ifcromakalim-induced vasodilation during hypoxia were caused by opening KATP channels, closing the channels should reverse the vasodilation. To test this possibility, glibenclamide was added to the perfusate after administration of the maximal dose (3 X 10-6 M) of cromakalim to the three hypoxic lungs in amounts calculated to achieve final concentrations of 10-7, 3 x 10-, 10-6, and 3 X 1O-6 M. After each dose of glibenclamide, adequate time was allowed for Ppal1o to reach a new steady-state.
Effects ofglucose and glibenclamide on the response to anoxia. To generate vasomotor responses to anoxia, the inspired oxygen tension at the intake port ofthe ventilator was decreased from 200 to 0 mmHg in a square-wave fashion at 60, 120, and 180 min of perfusion. After 30 min, PiO2 was returned to 200 mmHg.
To determine the effects of high glucose concentration on the anoxic response, we added either 15 mM glucose (n = 5) or 15 mM sucrose (n = 5) to the perfusate 15 min before the third anoxic exposure. This concentration of glucose was chosen because we had shown previously that it allowed vasoconstriction during severe hypoxia to be sustained (3). Sucrose, a disaccharide that is neither taken up nor metabolized, was used to control for possible osmotic effects of glucose.
To determine if the effects of high glucose concentration on the response to anoxia were due to an effect on KATP channels, we added either 5 gM glibenclamide plus 15 mM sucrose (n = 5), or glibenclamide vehicle (methanol) plus 15 mM sucrose (n = 5) to the perfusate 15 min before the third anoxic exposure (180 min). This concentration of glibenclamide was chosen on the basis of the concentration-response experiments described above in order to achieve complete inhibition of the KATp channels.
Effects ofglibenclamide on the response to moderate hypoxia. We found previously that hyperglycemia did not influence the pulmonary vascular response to moderate hypoxia (PiO2 = 30 mmHg) in isolated ferret lungs (3) . If our hypotheses were correct, glibenclamide also should have no effect on the vascular response to moderate hypoxia. Therefore, we exposed 10 lungs to PiO2 = 30 mmHg for 30 min at 60, 120, and 180 min of perfusion. 15 min before the third hypoxic exposure, we added either 5 AM glibenclamide plus 15 mM glucose (n = 5) or glibenclamide vehicle plus 15 mM glucose (n = 5) to the perfusate.
Effects of glibenclamide on the response to KCI. To determine whether glibenclamide affected the ability of pulmonary vascular smooth muscle to contract in a nonspecific fashion, vasoconstrictor responses to KCl were measured in hyperglycemic lungs perfused with blood containing 5 MM glibenclamide (n = 4) or vehicle (n = 4). The lungs were exposed to 30 min of moderate hypoxia at 60, 120, and 180 min, as described above. After completion of the third hypoxic exposure when PiO2 = 200 mmHg, KCI (1 M) was added to the perfusate, over 1-2 min, in amounts sufficient to achieve increases in perfusate potassium concentration of 10, 20, and 40 mM. At each concentration, 5-10 min were allowed for Ppa,00 to achieve a stable response. Ventilation was stopped and the trachea occluded just before administration of KCl to avoid secondary influences of bronchospasm on pulmonary vascular resistance.
Preparation ofsolutions. Glibenclamide (Sigma Chemical Co.) and cromakalim (Smith, Kline, and Beecham; King of Prussia, PA) were prepared before each experiment as 1-mM stock solutions. Glibenclamide was dissolved in methanol and cromakalim in distilled water. Glucose was added as a 2.8 M solution in water, and sucrose as a 1.5 M solution in water.
Statistical analysis. Results were analyzed using two factor (perfusate constituent, time) split-plot analysis of variance (16) . When a significant interaction was present, the least significant difference was calculated to allow comparison of means at each time point. Differences were considered significant when P < 0.05. Values in the text are means±SE.
Results
The pulmonary vascular response to increasing concentrations of cromakalim during moderate hypoxia is shown in Fig. 1 a.
Exposure to a PiO2 of 30 mmHg raised Ppalo1 from 13+0.5 to 45±2.0 mmHg (P < 0.05). Cromakalim caused a concentration-dependent decrease in Ppa1oo at concentrations 2 3 X 10-8, with an EC50 of 7 X IO-' M. The maximal concentration of cromakalim (3 X 10-6 M) reduced Ppalo1 to 15±0.5 mmHg.
As shown in Fig. 1 b, the vasodilation induced by 3 X 10-6 M cromakalim was progressively reversed by glibenclamide at concentrations > 10-7 M, with an ICe of 8 x 10-7 M. The (Fig. 2 a) . In contrast, glibenclamide lungs had less vasodilation (APpa1OO = -24±4.4 mmHg) and a greater sustained vasoconstriction (APpa1oo = 30±2.7 mmHg). Thus, the effects ofglibenclamide on the vascular response to anoxia (Fig. 2 b) were similar to the effects of glucose (Fig. 2 a) . There were no differences between glibenclamide and vehicle lungs in the vasomotor responses to the first and second anoxic exposures, which were performed before the addition of glibenclamide or vehicle.
As shown in Fig. 3 , glibenclamide had no effect on vasoconstrictor responses to moderate hypoxia (PiO2 = 30 mmHg). In contrast to anoxia, moderate hypoxia caused a slowly developing vasoconstriction (APpaloo = 39±2.5 mmHg) which peaked at 8.5±0.6 min and was followed by a slight vasodilation (APpa1oo = -4.6±0.9 mmHg).
Fig. 4 demonstrates that KC1 caused concentration-dependent increases in Ppaloo. Glibenclamide 
Discussion
The vasomotor response to anoxia in hypoglycemic ferret lungs was characterized by an intense early vasoconstriction followed by a marked vasodilation to baseline and finally a slight late vasoconstriction (Fig. 2 a) . Increasing perfusate glucose concentration to 14±0.4 mM (Fig. 2 a) striction. These results confirm our previous observations, which also demonstrated that the effects of high glucose concentration were not reproduced by normal (5 mM) glucose concentration (3). The cells best known for their ability to respond to high glucose concentrations are pancreatic beta cells, which release insulin. The mechanism of this response is thought to involve KATP channels in the plasma membrane ofthe beta cell (1 1, 12,   14 ). When glucose concentration is high, ATP production by these cells is increased. The resultant increase in ATP concentration causes closure ofthe KATn channels, leading to depolarization and secondary release ofinsulin. Sulfonylureas, such as glibenclamide and tolbutamide, are thought to cause insulin release from these cells by closing KATp channels (14, 17) . Presumably, this is the basis for the therapeutic efficacy of these agents in patients with adult-onset (Type II) diabetes mellitus.
High glucose concentration was also found to stimulate neuronal cells ofthe substantia nigra (13) . In this case, stimulation resulted in release of gammaaminobutyric acid (GABA). Because this response was also elicited by sulfonylureas and associated with decreased efflux of Rb+ (13), a K+ analogue (14) , it was thought to result from closure of KAT channels. Furthermore, when ATP concentration was reduced by anoxia, Rb+ efflux increased and GABA secretion was inhibited. Because the effects of anoxia were blocked by high glucose concentrations or sulfonylureas, they were also thought to be due to opening of KATP channels (13) .
The results ofthese studies (1 1-13) suggested that hypoglycemic lungs exposed to anoxia might have been unable to sustain hypoxic vasoconstriction (Fig. 2 a) because deficient ATP production caused opening of KATP channels, K+ efflux, hyperpolarization, and vasodilation. Furthermore, analogous to its effects in substantia nigra neurons, high glucose concentration may have allowed vasoconstriction to be sustained during anoxia by maintaining ATP concentrations at levels sufficient to keep KATP channels closed. In this study, we tested these possibilities by using the pharmacologic agents, cromakalim and glibenclamide.
Cromakalim is thought to open KATP channels (15) . For example, in vascular smooth muscle, cromakalim caused relaxation in association with hyperpolarization and increased Rb+ efflux (6, 7, 9) . These effects seemed to be relatively specific because single channel recordings demonstrated that cromakalim did not open Ca++-activated K+ channels in smooth muscle (6), and because inhibitors ofCa++-dependent K+ channels, such as charybdotoxin and apamin, did not block the effects of cromakalim in portal vein (7) . The EC50 of cromakalim's activation of KATP channels in systemic vascular smooth muscle was estimated to be 0.05-0.2 AM (7-9).
As stated above, glibenclamide is thought to close KATP channels (6, 8, 10, 13, 14, 17) . For example, in rat aortic rings contracted with KC1, glibenclamide (0.1-3 MM) had no effect on resting tension and inhibited cromakalim-induced relaxation, but did not inhibit relaxation induced by the calcium channel blockers, diltiazem and nitrendipine (8) . Single channel recordings of arterial smooth muscle cells also demonstrated that KAT channels were activated by cromakalim (1 ,M) and inactivated by the addition ofglibenclamide (20 MM) (6). As mentioned above, in substantia nigra neuronal cells, the increased Rb+ efflux caused by anoxia or depletion ofATP was reversed by glibenclamide (13) . Glibenclamide has not been demonstrated to block any other type ofK+ channel in smooth muscle or pancreatic cells (6, 14) . The EC.0 for these effects of glibenclamide varied between 0.1 and 10 MM (8, 9, 13). Our first experiment was designed to determine the effects ofcromakalim and glibenclamide on pulmonary vessels during hypoxia-induced vasoconstriction. As shown in Fig. 1 (6) (7) (8) (9) (10) . The vasodilation induced by cromakalim was reversed by glibenclamide at concentrations . 3 X 10-7 M (Fig. 1 b) , with an ICm of -0.8 MM. These concentrations are similar to those shown previously to close KATp channels (6, 8, 9) . Thus, these results suggested that KAT channels were present in the lung and capable of modulating pulmonary vasomotor tone during hypoxia.
Additional evidence that these channels modulated vascular tone in lung was recently obtained by Yuan et al. (18) and Eltze (19) who demonstrated that cromakalim inhibited hypoxiaand KCl-induced contractions in isolated pulmonary arteries, and that glibenclamide competitively antagonized the vasorelaxant effects of cromakalim.
Our second experiment was performed to determine if the effects of glibenclamide on the response to anoxia were similar to those of high glucose concentration. As shown in Fig. 2 b, glibenclamide markedly inhibited the vasodilator phase of the anoxic response, allowing the initial vasoconstriction to be better sustained in the absence ofglucose. These results were similar to those of high glucose concentration (Fig. 2 a) , and are consistent with the hypothesis that high glucose concentration allowed vasoconstriction to be sustained during anoxia because it maintained ATP production and closure of KAT channels.
To determine if the effects of glibenclamide were due to nonspecific potentiation ofvasoconstriction, we determined its effects on pulmonary vasoconstrictor responses to moderate hypoxia or KC1, which we previously demonstrated to be unaffected by glucose (3) . As shown in Figs. 3 and 4 , glibenclamide did not affect the vasoconstrictor response to either moderate hypoxia or KC1, suggesting that KATP channels did not modulate vasoconstriction under these conditions. In these experiments, the effects of glibenclamide again resembled those of high glucose concentrations (3). Thus, neither glibenclamide nor hyperglycemia appeared to alter the anoxic response through a nonspecific potentiation of vasoconstriction.
Recently, it was concluded that glibenclamide acted as a competitive antagonist of the thromboxane receptor in canine coronary artery (20) . It is not clear how this action, if present in our experiments, could explain our results, because thromboxane causes pulmonary vasoconstriction (21) , and inhibition of thromboxane and prostaglandin synthesis by indomethacin did not prevent reversal of hypoxic pulmonary vasoconstriction during severe hypoxia (22).
Our results are compatible with those of Daut and colleagues (10), who found that coronary vasodilation induced in isolated perfused guinea pig hearts by anoxia, dinitrophenol, cyanide, or cromakalim was inhibited by glibenclamide, whereas vasodilation caused by bradykinin was unaffected. They concluded that coronary arteries dilated in response to anoxia because depletion of ATP caused activation of KATP channels and secondary smooth muscle relaxation. The isolated heart differed from the isolated lung in that anoxic vasodilation in the coronary vasculature was not preceded by transient vasoconstriction. Thus, while the pulmonary vasculature characteristically constricts in response to hypoxia, during severe hypoxia it appears to share a mechanism of vasodilation with the coronary vasculature.
Our results are inconsistent with those of Robertson and colleagues (23) , who found, in isolated rat lungs, that high concentrations oftolbutamide (1.7 X 10-4-8.5 X O-' M) inhibited or abolished vasoconstrictor responses of isolated rat lungs to 2% 02, whereas high concentrations of diazoxide (1.1 X IO-' M) caused vasoconstriction during normoxia. Because tolbutamide, like glibenclamide, is thought to close KATP channels (14) , and diazoxide, like cromakalim, is thought to open them (24) , the authors speculated that hypoxia activated KATP channels in cells other than smooth muscle, resulting in hyperpolarization and secondary release of factors that caused vasoconstriction. We cannot explain the discrepancies in results other than to suggest that at high concentrations, tolbutamide and diazoxide could have nonspecific effects or that the effects of these agents differ among species.
As shown in Figs. 2 B and 3, glibenclamide did not cause vasoconstriction during normoxia, suggesting that KATP channels were closed during baseline conditions. This observation, which has also been made in pulmonary and systemic vascular smooth muscle, differs from results in the pancreatic betacell, where a proportion of the channels are thought to be open under normoxic, normoglycemic conditions (8, 9, 11, 14, 18, 19) .
Our data provide no insight concerning the location of KATP channels apparently involved in modulation of the response to anoxia. Although these channels are found in vascular smooth muscle (6) , it is possible that the vasodilation phase of the anoxic response (Fig. 2 a) was due to activation of KATP channels in some other cell. One obvious possibility is endothelium, which is stimulated by hyperpolarization (25) and can release vasodilators such as endothelium-derived hyperpolarization factor (EDHF), which induces relaxation in association with increased Rb+ effilux in smooth muscle cells (26) .
In summary, our results indicate that (a) KAT channels were present in the isolated ferret lung and were capable of modulating pulmonary vasomotor tone, and (b) glibenclamide, like high glucose concentrations, permitted hypoxic vasoconstriction to be sustained during anoxia, but did not affect vasoconstrictor responses to moderate hypoxia or KC1. These results support the hypothesis that hypoxic vasoconstriction is not sustained during anoxia due to opening of KAT channels, and that high glucose concentrations increase ATP production sufficiently to maintain channel closure, thereby preventing K+ efflux, hyperpolarization, and vasodilation. Our data added to the growing evidence that KATP channels play an important role in modulating blood flow during periods ofdeprivation of substrates for ATP production (27) .
